News

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a preclinical study by Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center... Read more

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, according to a preclinical... Read more

Weill Cornell Medicine has received a five-year, $2.3 million grant from the Centers for Disease Control and Prevention to improve equitable access to care, quality of life and survival outcomes for young people with all... Read more

Prostate cancer hijacks the normal prostate’s growth regulation program to release the brakes and grow freely, according to Weill Cornell Medicine researchers. The discovery , published Dec. 13 in Nature Communications,... Read more

An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma researchers. The inhibitors... Read more

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine. The results could potentially lead to... Read more

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine researchers. Checkpoint... Read more

Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede their attack—blocking the energy supply T cells depend on. The study , published Oct. 23 in Nature,... Read more

The Sandra and Edward Meyer Cancer Center (MCC) of Weill Cornell Medicine and NewYork- Presbyterian Hospital is pleased to announce a new cancer clinical research leadership team: Vered Stearns, MD is Associate Director for... Read more